{
    "body": "Is the toxin produced by Clostridium botulinum always deadly?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/12926199", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20173718", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23871478", 
        "http://www.ncbi.nlm.nih.gov/pubmed/26866491", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24997242", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15244362", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19488551", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23097586", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22513950", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24867833", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17674683", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19160335", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20693440", 
        "http://www.ncbi.nlm.nih.gov/pubmed/26697417"
    ], 
    "ideal_answer": [
        "There are numerous examples where children and animals survived infection with clostridium botulinum."
    ], 
    "exact_answer": "no", 
    "concepts": [
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001905", 
        "http://www.disease-ontology.org/api/metadata/DOID:11976"
    ], 
    "type": "yesno", 
    "id": "58a341a660087bc10a000017", 
    "snippets": [
        {
            "offsetInBeginSection": 1759, 
            "offsetInEndSection": 1941, 
            "text": "Animals treated with trace elements recovered. It appears that intestinal microbiota dysbiosis and trace element deficiency could explain the extensive emergence of chronic Botulism.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24997242", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1082, 
            "offsetInEndSection": 1316, 
            "text": "The patient was treated with human botulism immune globulin and had rapid recovery in weakness. A stool sample from the patient was positive for Type A Clostridium botulinum toxin eventually confirming the diagnosis of infant botulism", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26697417", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1199, 
            "offsetInEndSection": 1363, 
            "text": "The botulism immunoglobulin was administered, and a diagnosis was confirmed with positive botulinum toxin in the stool samples. Full recovery was made by the infant", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23871478", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 189, 
            "text": "Botulinum neurotoxin (BoNT) serotype B (BoNT/B) is one of the serotypes of BoNT that causes deadly human botulism, though it is used clinically for treatment of many neuromuscular diseases.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20693440", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 197, 
            "offsetInEndSection": 311, 
            "text": "Foodborne botulism is a rare and sometimes fatal illness caused by consuming foods containing botulinum neurotoxin", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23097586", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 578, 
            "offsetInEndSection": 692, 
            "text": "To assess the effectiveness and safety of botulinum toxin in treating MPS, excluding MPS in neck and head muscles.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22513950", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 27, 
            "offsetInEndSection": 174, 
            "text": "Botulinum toxin (BTX) is one of the most potent bacterial toxins known and its effectiveness in the treatment of some pain syndromes is well known.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19488551", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 525, 
            "offsetInEndSection": 751, 
            "text": " An emerging treatment option to address these issues is the use of a paralyzing material such as botulinum toxin A (Botox) to decrease the appearance of the wrinkles, which yields a more esthetic and youthful facial appearanc", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17674683", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 249, 
            "offsetInEndSection": 413, 
            "text": "lthough BoNT is an extremely toxic molecule, it is now increasingly used for the treatment of disorders related to muscle hyperactivity and glandular hyperactivity.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26866491", 
            "endSection": "abstract"
        }
    ]
}